Page 86 - Read Online
P. 86

Moore et al. J Transl Genet Genom 2021;5:200-217  https://dx.doi.org/10.20517/jtgg.2021.08  Page 17

               12.      Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative
                   traits. Genet Epidemiol 2007;31:358-62.  DOI  PubMed
               13.      Gibson J, Morton NE, Collins A. Extended tracts of homozygosity in outbred human populations. Hum Mol Genet 2006;15:789-95.
                   DOI  PubMed
               14.      Pemberton TJ, Absher D, Feldman MW, Myers RM, Rosenberg NA, Li JZ. Genomic patterns of homozygosity in worldwide human
                   populations. Am J Hum Genet 2012;91:275-92.  DOI  PubMed  PMC
               15.      Keller MC, Visscher PM, Goddard ME. Quantification of inbreeding due to distant ancestors and its detection using dense single
                   nucleotide polymorphism data. Genetics 2011;189:237-49.  DOI  PubMed  PMC
               16.      Szpiech ZA, Xu J, Pemberton TJ, et al. Long runs of homozygosity are enriched for deleterious variation. Am J Hum Genet
                   2013;93:90-102.  DOI  PubMed  PMC
               17.      Enciso-Mora V, Hosking FJ, Houlston RS. Risk of breast and prostate cancer is not associated with increased homozygosity in outbred
                   populations. Eur J Hum Genet 2010;18:909-14.  DOI  PubMed  PMC
               18.      Spain SL, Cazier JB, Houlston R, Carvajal-Carmona L, Tomlinson I; CORGI Consortium. Colorectal cancer risk is not associated with
                   increased levels of homozygosity in a population from the United Kingdom. Cancer Res 2009;69:7422-9.  DOI  PubMed
               19.      Hosking FJ, Papaemmanuil E, Sheridan E, et al. Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia
                   risk. Blood 2010;115:4472-7.  DOI  PubMed
               20.      Thomsen H, Inacio da Silva Filho M, Fuchs M, et al. Evidence of inbreeding in Hodgkin lymphoma. PLoS One 2016;11:e0154259.
                   DOI  PubMed  PMC
               21.      Sud A, Cooke R, Swerdlow AJ, Houlston RS. Genome-wide homozygosity signature and risk of Hodgkin lymphoma. Sci Rep
                   2015;5:14315.  DOI  PubMed  PMC
               22.      Joshi PK, Esko T, Mattsson H, et al. Directional dominance on stature and cognition in diverse human populations. Nature
                   2015;523:459-62.  DOI  PubMed  PMC
               23.      Conde L, Halperin E, Akers NK, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat
                   Genet 2010;42:661-4.  DOI  PubMed  PMC
               24.      Vivo I, Prescott J, Setiawan VW, et al; Australian National Endometrial Cancer Study Group. Genome-wide association study of
                   endometrial cancer in E2C2. Hum Genet 2014;133:211-24.  DOI  PubMed  PMC
               25.      Smedby KE, Foo JN, Skibola CF, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared
                   genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet 2011;7:e1001378.  DOI  PubMed  PMC
               26.      Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and
                   richer datasets. Gigascience 2015;4:7.  DOI  PubMed  PMC
               27.      Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am
                   J Hum Genet 2007;81:559-75.  DOI  PubMed  PMC
               28.      Gazal S, Sahbatou M, Perdry H, Letort S, Génin E, Leutenegger AL. Inbreeding coefficient estimation with dense SNP data:
                   comparison of strategies and application to HapMap III. Hum Hered 2014;77:49-62.  DOI  PubMed
               29.      Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011;88:76-82.
                   DOI  PubMed  PMC
               30.      Yengo L, Zhu Z, Wray NR, et al. Detection and quantification of inbreeding depression for complex traits from SNP data. Proc Natl
                   Acad Sci U S A 2017;114:8602-7.  DOI  PubMed  PMC
               31.      Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics
                   2010;26:2190-1.  DOI  PubMed  PMC
               32.      Edelmann J, Holzmann K, Miller F, et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent
                   genomic alterations. Blood 2012;120:4783-94.  DOI  PubMed
               33.      Puiggros A, Blanco G, Espinet B. Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go. Biomed Res
                   Int 2014;2014:435983.  DOI  PubMed  PMC
               34.      Goldin LR, Björkholm M, Kristinsson SY, Turesson I, Landgren O. Elevated risk of chronic lymphocytic leukemia and other indolent
                   non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica 2009;94:647-53.  DOI
                   PubMed  PMC
               35.      Malek SN. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in
                   chronic lymphocytic leukemia. Oncogene 2013;32:2805-17.  DOI  PubMed  PMC
               36.      Rawstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med
                   2008;359:575-83.  DOI  PubMed
               37.      Valentino T, Palmieri D, Vitiello M, Pierantoni GM, Fusco A, Fedele M. PATZ1 interacts with p53 and regulates expression of p53-
                   target genes enhancing apoptosis or cell survival based on the cellular context. Cell Death Dis 2013;4:e963.  DOI  PubMed  PMC
               38.      Chen Y, Wang J, Wang X, et al. Pik3ip1 is a negative immune regulator that inhibits antitumor T-cell immunity. Clin Cancer Res
                   2019;25:6180-94.  DOI  PubMed
               39.      Paulucci BP, Pereira J, Picciarelli P, Levy D, di Francesco RC. Expression of CysLTR1 and 2 in maturating lymphocytes of
                   hyperplasic tonsils compared to peripheral cells in children. Inflammation 2016;39:1216-24.  DOI  PubMed
               40.      Linet MS, Vajdic CM, Morton LM, et al. Medical history, lifestyle, family history, and occupational risk factors for follicular
                   lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014;2014:26-40.  DOI  PubMed
                   PMC
               41.      Wang SS, Carrington M, Berndt SI, et al. HLA Class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin
   81   82   83   84   85   86   87   88   89   90   91